Hidradenitis Suppurativa

Latest News

HS Uncovered: Global Survey Highlights Patient Perspectives and Psychosocial Impact
HS Uncovered: Global Survey Highlights Patient Perspectives and Psychosocial Impact

June 20th 2025

A global survey reveals the significant psychosocial and financial burdens of hidradenitis suppurativa, highlighting the need for improved patient care and treatment options.

ICYMI: FDA Grants Adalimumab-aaty Interchangeability Designation
ICYMI: FDA Grants Adalimumab-aaty Interchangeability Designation

May 23rd 2025

Uncovering Inequities in Hidradenitis Suppurativa Trials
Uncovering Inequities in Hidradenitis Suppurativa Trials

May 12th 2025

Off-Label Ixekizumab is Effective for HS After Treatment Failure with Adalimumab
Off-Label Ixekizumab is Effective for HS After Treatment Failure with Adalimumab

May 5th 2025

Patient Survey Highlights Dissatisfaction and Undertreatment in Hidradenitis Suppurativa Care
Patient Survey Highlights Dissatisfaction and Undertreatment in Hidradenitis Suppurativa Care

April 4th 2025

Latest CME Events & Activities

Cases and Conversations™: Biologic Matchmaking in Psoriasis – Finding the Right Therapy for the Right Patient

July 26, 2025

Register Now!

Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color

View More

Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach

View More

Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis

View More

Cases and Conversations™: Applying Practice Techniques to Optimize Diagnosis and Treatment Strategies in Generalized Pustular Psoriasis

View More

Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice

View More

‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis

View More

Dermalorian™ Webinar: Shedding Light on Patient-Reported Outcomes to Assess Disease Severity in Patients With Atopic Dermatitis

View More

Where Do Biologics Fit Into the Management of Moderate-to-Severe Atopic Dermatitis?

View More

Expert Illustrations & Commentaries™: Exploring Novel Therapeutic Targets in Acne Management

View More

Burst CME: Targeted Therapy for Optimal Psoriasis Management

View More

Clinical Consultations™: Providing Holistic Care for Complex Cases of Psoriasis with Cardiovascular Comorbidities

View More

Understanding Topical Steroid Withdrawal (TSW) in Patients With Atopic Dermatitis (AD)

View More

More News

© 2025 MJH Life Sciences

All rights reserved.